Mankind Pharma Ltd
Fortune 500 2025
+ 3 More
+ 3 More
Share
Share
OVERVIEW
FINANCIALS
NEWS
Featured In Fortune India Ranking
Fortune 500 India
#210(2025)
#227(2024)
#250(2023)
#213(2022)
#210(2025)#227(2024)#250(2023)#213(2022)
Financial Data 2024
Revenue
10,726
(INR Cr)
Net Operating Income
10,335
(INR Cr)
Assets
9,929
(INR Cr)
Profit
1,913
(INR Cr)
Net Worth
9,363
(INR Cr)
Fortune India Coverage
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 10726 24.7% | 8601 1.9% | 8442 27.1% | 6644 10.8% | 5998 54.9% | 3871 -4.4% | 4050 9.6% | 3695 14.1% | 3238 -7.5% | 3500 49.1% | 2348 19.8% | 1959 11.2% | 1762 14.6% | 1538 35.7% | 1133 29.0% | 878 - |
| Net Operating Income (INR Cr) | 10335 18.12% | 8749 12.44% | 7782 25.22% | 6214 5.95% | 5865 0.00% | 3829 -2.27% | 3918 12.12% | 3495 10.96% | 3150 17.41% | 3334 0.00% | 2289 16.35% | 1967 19.17% | 1651 17.32% | 1407 29.57% | 1086 29.22% | 840 34.47% |
| Profit (INR Cr) | 1913 49.2% | 1282 -10.6% | 1433 13.3% | 1265 22.8% | 1030 100.5% | 514 -26.0% | 694 30.6% | 532 12.0% | 475 8.1% | 439 27.6% | 344 18.5% | 291 36.0% | 214 3.3% | 207 20.3% | 172 42.7% | 121 - |
| Assets (INR Cr) | 9929 25.4% | 7917 8.6% | 7290 40.6% | 5185 33.5% | 3884 17.8% | 3297 -2.7% | 3390 27.4% | 2662 25.7% | 2118 -0.2% | 2122 34.1% | 1582 28.2% | 1235 31.0% | 943 29.0% | 731 45.2% | 504 47.7% | 341 - |
| Net Worth (INR Cr) | 9363 25.9% | 7435 20.8% | 6155 30.4% | 4722 35.5% | 3485 0.0% | 3065 2.3% | 2997 13.6% | 2639 25.5% | 2102 7.3% | 2055 0.0% | 1556 28.4% | 1211 31.6% | 921 30.3% | 707 41.4% | 500 49.8% | 334 52.3% |
| Employee Cost (INR Cr) | 2275 18.6% | 1918 18.4% | 1621 14.5% | 1416 6.0% | 1336 70.1% | 785 -1.6% | 798 20.5% | 663 15.6% | 573 -0.7% | 577 62.8% | 354 18.5% | 299 26.2% | 237 26.0% | 188 34.5% | 140 35.6% | 103 - |
| Interest Cost (INR Cr) | 35 | 46 | 60 | 21 | 23 | 40 | 18 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Cash & Bank Balance (INR Cr) | 1198 | 453 | 406 | 701 | 420 | 72 | 81 | 92 | 69 | 39 | 100 | 105 | 89 | 83 | 100 | 60 |
| Total Debt (INR Cr) | 207 | 170 | 873 | 241 | 131 | 190 | 360 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 7 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 17.8% | 14.9% | 17.0% | 19.0% | 17.2% | 13.3% | 17.1% | 14.4% | 14.7% | 12.6% | 14.7% | 14.8% | 12.1% | 13.5% | 15.2% | 13.7% |
| Profit As % Of Assets | 19.3% | 16.2% | 19.7% | 24.4% | 26.5% | 15.6% | 20.5% | 20.0% | 22.4% | 20.7% | 21.8% | 23.5% | 22.7% | 28.3% | 34.2% | 35.4% |
| Profit As % Of Networth | 20.4% | 17.2% | 23.3% | 26.8% | 29.6% | 16.8% | 23.2% | 20.2% | 22.6% | 21.4% | 22.1% | 24.0% | 23.2% | 29.3% | 34.4% | 36.1% |
| Interest Cost to EBITDA % | 1.4% | 2.4% | 3.0% | 1.3% | 1.6% | 5.6% | 2.3% | 0.2% | 0.3% | 0.4% | 0.4% | 0.4% | 0.5% | 0.6% | 0.6% | 1.4% |
| Debt to Equity Ratio | 0.02 | 0.02 | 0.14 | 0.05 | 0.04 | 0.06 | 0.12 | - | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.01 | 0.02 |
| RONW | 23.1% | 19.3% | 26.7% | 31.5% | 30.3% | 17.0% | 24.6% | 22.4% | 23.4% | 21.6% | 24.9% | 27.3% | 26.3% | 34.3% | 41.3% | 43.6% |
| ROCE | 27.9% | 23.1% | 33.4% | 39.2% | 39.5% | 21.9% | 31.7% | 32.4% | 33.5% | 29.6% | 34.6% | 36.6% | 33.4% | 47.0% | 59.4% | 66.0% |